8 terminated. 8 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
| Phase 3 | 1 | Terminated 1 |
Follow Avitaminosis: new trials by email Literature Review of Avitaminosis trials Research Report on Avitaminosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients Denosumab Inj 60 mg/ml, Placebo - Osteoporosis, Renal Osteodystrophy | Phase 2 | Terminated | Thomas Nickolas, MD MS | 8 | 2020-01-16 | 2024-07-25 |
| Improving Functionality in Older People High dose Vitamin D3, Low dose Vitamin D3 - Vitamin D Deficiency | Phase 2 | Terminated | Texas Tech University Health Sciences Center | 14 | 2018-08-01 | 2019-07-23 |
| Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI Calcifediol Oral Capsule, Placebo oral capsule - Secondary Hyperparathyroidism Due to Renal Causes, Chronic Kidney Diseases | Phase 2 | Terminated | OPKO Health, Inc. | 44 | 2018-07-09 | 2026-04-03 |
| Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency. Cholecalciferol, Milk (Nestle) - Vitamin D Deficiency, Critical Illness | Phase 2 / Phase 3 | Terminated | King Abdullah Medical City | 127 | 2017-08-27 | 2020-06-18 |
| Thiamine vs. Placebo to Increase Oxygen Consumption After Cardiac Arrest Thiamine, placebo - Cardiac Arrest, Shock | Phase 2 | Terminated | Beth Israel Deaconess Medical Center | 41 | 2017-05-01 | 2025-04-10 |
| Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus Vitamin D3 6000 IU, Vitamin D3 400 IU - Systemic Lupus Erythematosus | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 7 | 2013-06-01 | 2015-12-17 |
| Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism Etelcalcetide - Secondary Hyperparathyroidism | Phase 2 | Terminated | KAI Pharmaceuticals | 30 | 2012-03-01 | 2017-04-13 |
| Studies With 1,25-Dihydroxycholecalciferol 1,25-Dihydroxycholecalciferol - Hypocalcemia, Rickets | Phase 2 | Terminated | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 | 1976-03-01 | 2013-11-25 |
Vitamin D Deficiency (4) · Chronic Kidney Disease-Mineral and Bone Disorder (2) · Acidosis, Lactic (1) · Beriberi (1) · Critical Illness (1) · Heart Arrest (1) · Hyperparathyroidism, Secondary (1) · Hypocalcemia (1) · Lupus Erythematosus, Systemic (1) · Osteoporosis (1) · Renal Insufficiency, Chronic (1) · Rickets (1) · Shock (1)
Deficiency Diseases (8) · Malnutrition (8) · Nutrition Disorders (8) · Nutritional and Metabolic Diseases (8) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Disease Attributes (4) · Metabolic Diseases (4) · Bone Diseases (3) · Bone Diseases, Metabolic (3) · Calcium Metabolism Disorders (3) · Chronic Disease (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3)
Cholecalciferol (3) · Calcifediol (1) · Calcitriol (1) · Denosumab (1) · Milk (1) · Saline Solution (1) · Thiamine (1) · Vitamin D (1) · etelcalcetide hydrochloride (1)
Beth Israel Deaconess Medical Center (1) · KAI Pharmaceuticals (1) · King Abdullah Medical City (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · OPKO Health, Inc. (1) · Texas Tech University Health Sciences Center (1) · Thomas Nickolas, MD MS (1)
United States (6) · Saudi Arabia (1)
Asiah S Rugaan, MD, MRCP (1) · Emily Von Scheven, MD, MAS (1) · Jon M Burnham, MD, MSCE (1) · Katherine M Berg, MD (1) · M D (1) · Stephen J Marx, MD (1) · Thomas Nickolas, MD, MS (1)
K23HL128814 (1)